# Hakim Charfi – FDA Inspection, Feb 25, 2022

Source: https://www.keypedia.com/records/fda_inspections/hakim-charfi/4a952e1e-85b9-4c4c-a241-96b39be2e0f8
Source feed: FDA_Inspections

> FDA inspection 1165965 of Hakim Charfi, February 25, 2022. Classification: No Action Indicated (NAI). 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1165965
- Company Name: Hakim Charfi
- Inspection Date: 2022-02-25
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1250592 - 2024-09-06
- [FDA Inspection 1115588 - 2019-12-13](https://www.keypedia.com/records/fda_inspections/hakim-charfi/d3a7d153-eb0b-45d0-84ba-cf321ad4e431)

Company: https://www.keypedia.com/companies/hakim-charfi/30bbf6cd-d812-4954-812f-c178511aef5c

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c